The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases.

Intestinal inflammation arises from abnormal host-microbe interactions. The perturbations of homeostatic coexistence involve host genetic factors, barrier function, innate and adaptive immunity, as well as qualitative and quantitative changes in the composition of the microbiota. Dysbiosis toward selected micro-organisms and decreased complexity of commensal bacteria have been observed in patients with Crohn's disease and ulcerative colitis, but it is not clear whether the dysbiosis contributes to development of inflammatory bowel disease or is instead a consequence of the disease. Pathogens with virulence factors that allow them to breach the intestinal barrier and induce chronic inflammation might mediate the pathogenesis of these diseases. To identify new therapeutic approaches for inflammatory bowel disease, it is important to identify host susceptibility factors involved in the control of microbial infection, characterize potential pathogens, and eliminate them or block the expression of their virulence factors.

[1]  J. Rioux,et al.  Crohn disease: A current perspective on genetics, autophagy and immunity , 2011, Autophagy.

[2]  Annick Harel-Bellan,et al.  A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease , 2011, Nature Genetics.

[3]  J. Hugot,et al.  Crohn disease--associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. , 2011, The Journal of clinical investigation.

[4]  J. Doré,et al.  Highlighting new phylogenetic specificities of Crohn's disease microbiota , 2011, Inflammatory bowel diseases.

[5]  Anders F. Andersson,et al.  A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.

[6]  Michael A McGuckin,et al.  Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria , 2010, The American Journal of Gastroenterology.

[7]  N. Cerf-Bensussan,et al.  The immune system and the gut microbiota: friends or foes? , 2010, Nature Reviews Immunology.

[8]  N. Barnich,et al.  Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion , 2010, Gut.

[9]  Si Ming Man,et al.  Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease , 2010, Inflammatory bowel diseases.

[10]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[11]  M. Egger,et al.  Long-term antibiotic treatment for Crohn's disease: systematic review and meta-analysis of placebo-controlled trials. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  R. Xavier,et al.  Crohn's disease‐associated adherent‐invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly , 2010, Cellular microbiology.

[13]  W. Lehmann,et al.  Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: A clue to pathogenesis , 2009, Inflammatory bowel diseases.

[14]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[15]  G. Weinstock,et al.  Enteric defensins are essential regulators of intestinal microbial ecology , 2009, Nature Immunology.

[16]  Annaïg Lan,et al.  The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. , 2009, Immunity.

[17]  A. Sivignon,et al.  Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM , 2009, The Journal of experimental medicine.

[18]  S. Gray-Owen,et al.  Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epithelia , 2009, BMC Microbiology.

[19]  D. Ron,et al.  Adaptive Suppression of the ATF4-CHOP Branch of the Unfolded Protein Response by Toll-Like Receptor Signaling , 2009, Nature Cell Biology.

[20]  K. Gradel,et al.  Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. , 2009, Gastroenterology.

[21]  J. Satsangi,et al.  Dysregulation of Human β-Defensin-2 Protein in Inflammatory Bowel Disease , 2009, PloS one.

[22]  J. Blanco,et al.  Molecular diversity of Escherichia coli in the human gut: New ecological evidence supporting the role of adherent‐invasive E. coli (AIEC) in Crohn's disease , 2009, Inflammatory bowel diseases.

[23]  K. Lundin,et al.  Isolation of Mycobacterium avium Subspecies paratuberculosis Reactive CD4 T Cells from Intestinal Biopsies of Crohn's Disease Patients , 2009, PloS one.

[24]  I. Petersen,et al.  Prevalence of infectious pathogens in Crohn's disease. , 2009, Pathology, research and practice.

[25]  Bernard Henrissat,et al.  Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla , 2009, Proceedings of the National Academy of Sciences.

[26]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[27]  K. Itoh,et al.  Bacteroides Induce Higher IgA Production Than Lactobacillus by Increasing Activation-Induced Cytidine Deaminase Expression in B Cells in Murine Peyer’s Patches , 2009, Bioscience, biotechnology, and biochemistry.

[28]  A. Bitton,et al.  Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: A randomized, double‐blind, placebo‐controlled pilot study , 2009, Inflammatory bowel diseases.

[29]  Y. Benno,et al.  Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis , 2009, Scandinavian journal of gastroenterology.

[30]  Si Ming Man,et al.  Detection and Isolation of Campylobacter Species Other than C. jejuni from Children with Crohn's Disease , 2008, Journal of Clinical Microbiology.

[31]  Sarah L. Brown,et al.  A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells , 2008, Nature.

[32]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[33]  D. Rifkin,et al.  Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. , 2008, Cell host & microbe.

[34]  H. Tilg,et al.  XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease , 2008, Cell.

[35]  M. Kamm,et al.  Dynamics of the Mucosa-Associated Flora in Ulcerative Colitis Patients during Remission and Clinical Relapse , 2008, Journal of Clinical Microbiology.

[36]  J. Hugot,et al.  Nod2 Mediates Susceptibility to Yersinia pseudotuberculosis in Mice , 2008, PloS one.

[37]  A. Torres,et al.  Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. , 2008, International journal of medical microbiology : IJMM.

[38]  Judy H. Cho,et al.  The genetics and immunopathogenesis of inflammatory bowel disease , 2008, Nature Reviews Immunology.

[39]  J. Söderholm,et al.  Increased uptake of non‐pathogenic E. coli via the follicle‐associated epithelium in longstanding ileal Crohn's disease , 2008, The Journal of pathology.

[40]  R. W. Bentley,et al.  Incidence of Mycobacterium avium Subspecies paratuberculosis in a Population-Based Cohort of Patients With Crohn's Disease and Control Subjects , 2008, The American Journal of Gastroenterology.

[41]  C. Goodnow,et al.  Aberrant Mucin Assembly in Mice Causes Endoplasmic Reticulum Stress and Spontaneous Inflammation Resembling Ulcerative Colitis , 2008, PLoS medicine.

[42]  R. Flavell,et al.  An Antibiotic-Responsive Mouse Model of Fulminant Ulcerative Colitis , 2008, PLoS medicine.

[43]  N. Borruel,et al.  Unstable Composition of the Fecal Microbiota in Ulcerative Colitis During Clinical Remission , 2008, The American Journal of Gastroenterology.

[44]  J. Doré,et al.  Dysbiosis in inflammatory bowel disease: a role for bacteriophages? , 2008, Gut.

[45]  J. Gordon,et al.  IgA response to symbiotic bacteria as a mediator of gut homeostasis. , 2007, Cell host & microbe.

[46]  Wendy S. Garrett,et al.  Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System , 2007, Cell.

[47]  Martin Wiedmann,et al.  Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum , 2007, The ISME Journal.

[48]  G. Dougan,et al.  Salmonella enterica Serovar Typhimurium Exploits Inflammation to Compete with the Intestinal Microbiota , 2007, PLoS biology.

[49]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[50]  B. Finlay,et al.  Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. , 2007, Cell host & microbe.

[51]  Yoshihide Fujiyama,et al.  Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis , 2007, Inflammatory bowel diseases.

[52]  P. Gerner-Smidt,et al.  Invasive Escherichia coli are a feature of Crohn's disease , 2007, Laboratory Investigation.

[53]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[54]  J. Hugot,et al.  CARD15/NOD2 Is Required for Peyer's Patches Homeostasis in Mice , 2007, PloS one.

[55]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[56]  N. Barnich,et al.  CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. , 2007, The Journal of clinical investigation.

[57]  W. Selby,et al.  Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. , 2007, Gastroenterology.

[58]  Shailesh Singh,et al.  Influence of Mycobacterium avium subsp. paratuberculosis on Colitis Development and Specific Immune Responses during Disease , 2007, Infection and Immunity.

[59]  B. Payre,et al.  Adherent‐invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro , 2007, Cellular microbiology.

[60]  H. Kiyono,et al.  Therapeutic effects of roxithromycin in interleukin‐10‐deficient colitis , 2007, Inflammatory bowel diseases.

[61]  Judy H Cho,et al.  Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.

[62]  S. Fisher,et al.  A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. , 2007, Gastroenterology.

[63]  Thomas Lengauer,et al.  A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 , 2007, Nature Genetics.

[64]  S. Brant,et al.  Testing the Interaction between NOD-2 Status and Serological Response to Mycobacterium paratuberculosis in Cases of Inflammatory Bowel Disease , 2007, Journal of Clinical Microbiology.

[65]  J. Garcia-Gil,et al.  Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction‐denaturing gradient gel electrophoresis , 2006, Inflammatory bowel diseases.

[66]  D. Teitelbaum,et al.  Colostomy: formation and closure , 2006 .

[67]  Shadi Sepehri,et al.  High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease , 2006, Gut.

[68]  L. Hooper,et al.  Symbiotic Bacteria Direct Expression of an Intestinal Bactericidal Lectin , 2006, Science.

[69]  F. Theissig,et al.  Comparative study of the intestinal mucus barrier in normal and inflamed colon , 2006, Gut.

[70]  J. Harel,et al.  Adherent and Invasive Escherichia coli Is Associated with Granulomatous Colitis in Boxer Dogs , 2006, Infection and Immunity.

[71]  U Wahnschaffe,et al.  Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease , 2006, Gut.

[72]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[73]  J. Mallet,et al.  Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. , 2006, Gastroenterology.

[74]  S. Cucchiara,et al.  Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease , 2006, Gut.

[75]  Klaus Ley,et al.  The primary defect in experimental ileitis originates from a nonhematopoietic source , 2006, The Journal of experimental medicine.

[76]  C. Tung,et al.  The Crohn's disease‐associated adherent‐invasive Escherichia coli strain LF82 replicates in mature phagolysosomes within J774 macrophages , 2006, Cellular microbiology.

[77]  M. Weichenthal,et al.  Reduced Paneth cell α-defensins in ileal Crohn's disease , 2005 .

[78]  C. Manichanh,et al.  Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.

[79]  S. Mazmanian,et al.  An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System , 2005, Cell.

[80]  R. Sartor,et al.  Does Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease? , 2005, Gut.

[81]  E. Vik,et al.  Inflammatory bowel disease associated with Yersinia enterocolitica O:3 infection. , 2005, European journal of internal medicine.

[82]  D. Rampton,et al.  Molecular Characterization of Rectal Mucosa‐Associated Bacterial Flora in Inflammatory Bowel Disease , 2005, Inflammatory bowel diseases.

[83]  V. Deretic,et al.  Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected Macrophages , 2004, Cell.

[84]  M Schwab,et al.  NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression , 2004, Gut.

[85]  Laurent Beaugerie,et al.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.

[86]  C. Hart,et al.  Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. , 2004, Gastroenterology.

[87]  R Balfour Sartor,et al.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.

[88]  S. Targan,et al.  Bacterial flagellin is a dominant antigen in Crohn disease , 2004 .

[89]  Keiichiro Suzuki,et al.  Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[90]  W. Mow,et al.  Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. , 2004, Gastroenterology.

[91]  H. Harmsen,et al.  Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice , 2003, Gut.

[92]  Jeffrey I. Gordon,et al.  Angiogenins: a new class of microbicidal proteins involved in innate immunity , 2003, Nature Immunology.

[93]  M. Bronner,et al.  Pathogenic Yersinia DNA Is Detected in Bowel and Mesenteric Lymph Nodes From Patients With Crohn's Disease , 2003, The American journal of surgical pathology.

[94]  J. Doré,et al.  Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon , 2003, Gut.

[95]  Keiichiro Suzuki,et al.  Critical Roles of Activation-Induced Cytidine Deaminase in the Homeostasis of Gut Flora , 2002, Science.

[96]  C. Neut,et al.  Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease , 2002, American Journal of Gastroenterology.

[97]  Jean-Frederic Colombel,et al.  Adherent Invasive Escherichia coli Strains from Patients with Crohn's Disease Survive and Replicate within Macrophages without Inducing Host Cell Death , 2001, Infection and Immunity.

[98]  F. Autschbach,et al.  Inflammatory bowel disease is associated with changes of enterocytic junctions. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[99]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[100]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[101]  J. Boudeau,et al.  Invasive Ability of an Escherichia coliStrain Isolated from the Ileal Mucosa of a Patient with Crohn’s Disease , 1999, Infection and Immunity.

[102]  V. Godfrey,et al.  IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[103]  N. Barnich,et al.  Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. , 1998, Gastroenterology.

[104]  R. Sartor,et al.  Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.

[105]  R. Pounder,et al.  Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues. , 1998, Journal of clinical pathology.

[106]  A. Imaoka,et al.  Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain , 1998, Gut.

[107]  J. Sundberg,et al.  CD4+ T Cells Reactive to Enteric Bacterial Antigens in Spontaneously Colitic C3H/HeJBir Mice: Increased T Helper Cell Type 1 Response and Ability to Transfer Disease , 1998, The Journal of experimental medicine.

[108]  P. Rutgeerts,et al.  Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. , 1998, Gastroenterology.

[109]  M. Neurath,et al.  Responses to self and non-self intestinal microflora in health and inflammatory bowel disease. , 1997, Research in immunology.

[110]  R. Hammer,et al.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. , 1996, The Journal of clinical investigation.

[111]  A. West,et al.  Immunocytochemical evidence of Listeria, Escherichia coil, and Streptococcus antigens in Crohn's disease , 1995, Gastroenterology.

[112]  J. Sundberg,et al.  Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. , 1994, Gastroenterology.

[113]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[114]  S. Tonegawa,et al.  Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages , 1992, Nature.

[115]  S. Rastan,et al.  Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells. , 1992, Science.

[116]  P. Rutgeerts,et al.  Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum , 1991, The Lancet.

[117]  R. Hammer,et al.  Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β 2m: An animal model of HLA-B27-associated human disorders , 1990, Cell.

[118]  J. Rotter,et al.  Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. , 1986, Annals of internal medicine.

[119]  B. Morson.  The Early Histological Lesion of Crohn's Disease , 1972, Proceedings of the Royal Society of Medicine.

[120]  D. Jewell,et al.  NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation , 2010, Nature Medicine.

[121]  D. Philpott,et al.  Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry , 2010, Nature Immunology.

[122]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[123]  Manfred Dietel,et al.  Mucosal flora in inflammatory bowel disease. , 2002, Gastroenterology.

[124]  A. Hayday,et al.  T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. , 1997, The American journal of pathology.